| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 75,000 | $5,325 | $0.0710 | 09 Oct 2024 | Direct |
| Molecular Templates, Inc. | Chief Medical Officer | Stock Option (right to buy) | 170,000 | 15 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | 09 Oct 2024 | 1 | $0 | 4 | Chief Medical Officer | 10 Oct 2024, 16:05 |
| INDP | Indaptus Therapeutics, Inc. | 22 Jan 2024 | 1 | $0 | 4 | Chief Medical Officer | 23 Jan 2024, 16:15 |
| INDP | Indaptus Therapeutics, Inc. | 07 Aug 2023 | 1 | $0 | 4 | Chief Medical Officer | 07 Aug 2023, 17:25 |
| INDP | Indaptus Therapeutics, Inc. | 07 Aug 2023 | 0 | $0 | 3 | Chief Medical Officer | 07 Aug 2023, 17:24 |
| /report/000089924323005364-waltzman-roger-j-2023-02-15 | Molecular Templates, Inc. | 15 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 17 Feb 2023, 07:00 |
| /report/000089924322006731-waltzman-roger-j-2022-02-15 | Molecular Templates, Inc. | 15 Feb 2022 | 1 | $0 | 4 | Chief Medical Officer | 17 Feb 2022, 07:07 |